Related references
Note: Only part of the references are listed.Sorafenib Induces Therapeutic Response in a Patient with Metastatic Collecting Duct Carcinoma of Kidney
Jawaher Ansari et al.
ONKOLOGIE (2009)
Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma
Brian I. Rini et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma
Toni K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Use of Von-Hippel Lindau (VHL) mutation status to predict objective response to vascular endothelial growth factor (VEGF) - targeted therapy in metastatic renal cell carcinoma (RCC)
T. K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: Results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Genitales) study
Setphane Oudard et al.
JOURNAL OF UROLOGY (2007)
Collecting duct (Bellini duct) renal cell carcinoma: A nationwide survey in Japan
Noriaki Tokuda et al.
JOURNAL OF UROLOGY (2006)
Collecting duct carcinoma of the kidney:: A clinicopathological study of 9 cases
M Peyromaure et al.
JOURNAL OF UROLOGY (2003)
Active chemotherapy for collecting duct carcinoma of the kidney - A case report and review of the literature
MI Milowsky et al.
CANCER (2002)
Collecting duct renal cell carcinoma: Clinical study of a rare tumor
D Chao et al.
JOURNAL OF UROLOGY (2002)
Share Paper
